Skip to content

Effect Observation of General Anesthesia Combined with Ultrasound-guided Superior Arcuate Ligament Quadratus Lumborum Block in Analgesia during Laparoscopic Total Hysterectomy

Effect Observation of General Anesthesia Combined with Ultrasound-guided Superior Arcuate Ligament Quadratus Lumborum Block in Analgesia during Laparoscopic Total Hysterectomy

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2500096653
Enrollment
Unknown
Registered
2025-01-27
Start date
2025-03-01
Completion date
Unknown
Last updated
2025-02-03

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

None listed

Interventions

Sponsors

Mindong Hospital of Ningde(Mindong Hospital Affiliated to Fujian Medical University)
Lead Sponsor

Eligibility

Sex/Gender
Female

Inclusion criteria

Inclusion criteria: 1.Patients undergoing elective laparoscopic hysterectomy; 2.United States American Society of Anes-thesiologists (ASA) class I-II; 3.Body mass index (BMI) >=20 and <= 35 kg/m^2; 4.Normal laboratory indicators such as liver function, kidney function, and coagulation function; 5.Able to cooperate well with postoperative resting, exercise and visceral pain scores; Able to properly use an intravenous self-controlled analgesic pump under the guidance of a nurse.

Exclusion criteria

Exclusion criteria: 1.Patients with cognitive dysfunction before and after surgery, who are unable to cooperate in pain assessment; 2.Patients with severe mental disorders; 3.Patients with severe cardiovascular and cerebrovascular diseases such as unstable angina pectoris, severe arrhythmia, severe valvular heart disease, cerebral infarction, etc.; 4.Patients with abnormal liver or kidney function, coagulation disorders, or blood system infections; 5.Patients with infection or tumor lesions at the puncture site; 6.Patients in shock; 7.Patients allergic to local anesthetics; 8.Patients have severe spinal deformities.

Design outcomes

Primary

MeasureTime frame
Hydromorphone consumption in the first 12 hours after surgery;

Secondary

MeasureTime frame
Visual analogue scale (at rest and during exercise);Mean arterial pressure ;Inflammatory markers (IL-6, IL-10, TNF-a);Bruggrmann comfort sealed,BCS;The time of the first self-controlled use of the analgesic pump after surgery;The total dose of hydromorphone used.;Perioperative adverse reactions;Heart rate;

Countries

China

Contacts

Public ContactHuang Qingqing

Mindong Hospital of Ningde(Mindong Hospital Affiliated to Fujian Medical University)

494325099@qq.com+86 135 9919 8422

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026